Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 397Xls
2D Structure
Also known as: Ademol, Trifluoromethylthiazide, Flumethiazid, Flumetiazid, 148-56-1, Fludemil
Molecular Formula
C8H6F3N3O4S2
Molecular Weight
329.3  g/mol
InChI Key
RGUQWGXAYZNLMI-UHFFFAOYSA-N
FDA UNII
3PA0CDS0M5

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1,1-dioxo-6-(trifluoromethyl)-4H-16,2,4-benzothiadiazine-7-sulfonamide
2.1.2 InChI
InChI=1S/C8H6F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-3H,(H,13,14)(H2,12,15,16)
2.1.3 InChI Key
RGUQWGXAYZNLMI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=C(C(=CC2=C1NC=NS2(=O)=O)S(=O)(=O)N)C(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
3PA0CDS0M5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ademol

2.3.2 Depositor-Supplied Synonyms

1. Ademol

2. Trifluoromethylthiazide

3. Flumethiazid

4. Flumetiazid

5. 148-56-1

6. Fludemil

7. Ademil

8. Routrax

9. Trifluomethylthiazide

10. Nsc 44626

11. Trifluoromethyl Thiazide

12. Nsc-44626

13. 3pa0cds0m5

14. 6-(trifluoromethyl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

15. 4h-1,2,4-benzothiadiazine-7-sulfonamide, 6-(trifluoromethyl)-, 1,1-dioxide

16. Flumethiazide (inn)

17. Flumethiazide [inn]

18. Flumetiazide [dcit]

19. Flumethazide

20. Flumethiazidum

21. Flumetiazida

22. Flumetiazide

23. Flumethiazide [inn:ban]

24. 2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-(trifluoromethyl)-, 1,1-dioxide

25. Flumethiazidum [inn-latin]

26. Flumetiazida [inn-spanish]

27. Hsdb 2845

28. Einecs 205-717-4

29. Unii-3pa0cds0m5

30. Ademol (tn)

31. 6-trifluoromethyl-7-sulfamyl-1,2,4-benzothiadiazine 1,1-dioxide

32. 6-trifluoromethyl-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide

33. 6-(trifluoromethyl)-1,2,4-benzo-thiadiazine-7-sulfonamide 1,1-dioxide

34. 6-(trifluoromethyl)-1,4,2-benzothiadiazine-7-sulfonamido 1,1-dioxide

35. 6-trifluoromethyl-7-sulfamoyl-4h-1,2,4-benzothiadiazine 1,1-dioxide

36. 6-trifluoromethyl-7-sulfamoyl-4h-1,4,2-benzothiadiazine 1,1-dioxide

37. 7-sulfamoyl-6-trifluoromethyl-2h-1,2,4-benzothiadiazine 1,1-dioxide

38. Flumethiazide [mi]

39. Flumethiazide [hsdb]

40. Schembl26534

41. Flumethiazide [vandf]

42. Flumethiazide [who-dd]

43. Chembl2105128

44. Dtxsid60163862

45. Chebi:135404

46. Nsc44626

47. Wln: T66 Bswm Enj Hxfff Iszw

48. D02453

49. Q27257858

50. 6-trifluoromethyl-7-sulfamyl-1,4-benzothiadiazine 1,1-dioxide

51. 6-(trifluoromethyl)-1,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

52. 6-(trifluoromethyl)-1,4-benzothiadiazine-7-sulfonamido 1,1-dioxide

53. 6-trifluoromethyl-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide

54. 6-trifluoromethyl-7-sulfamoyl-4h-1,4-benzothiadiazine 1,1-dioxide

55. 7-sulfamoyl-6-trifluoromethyl-2h-1,4-benzothiadiazine 1,1-dioxide

56. 1,1-dioxo-6-(trifluoromethyl)-4h-benzo[e][1,2,4]thiadiazine-7-sulfonamide

57. 2h-1,4-benzothiadiazine-7-sulfonamide, 6-(trifluoromethyl)-, 1,1-dioxide

58. 4h-1,4-benzothiadiazine-7-sulfonamide, 6-(trifluoromethyl)-, 1,1-dioxide

59. 1,1-dioxo-6-(trifluoromethyl)-4h-1lambda6,2,4-benzothiadiazine-7-sulfonamide

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 329.3 g/mol
Molecular Formula C8H6F3N3O4S2
XLogP3-0.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count1
Exact Mass328.97518251 g/mol
Monoisotopic Mass328.97518251 g/mol
Topological Polar Surface Area135 Ų
Heavy Atom Count20
Formal Charge0
Complexity617
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

...AVAILABLE AS TABLETS FOR ORAL ADMIN. ...GIVEN IN DIVIDED DAILY DOSES FOR TREATMENT OF HYPERTENSION, BUT SINGLE DAILY DOSE MAY BE PREFERABLE FOR MOBILIZATION OF EDEMA FLUID. ... LESS COMMON USAGES...INCL TREATMENT OF DIABETES INSIPIDUS & MGMNT OF HYPERCALCIURIA IN PT WITH...URINARY CALCULI... /BENZOTHIADIAZIDES/

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 832


THIAZIDES HAVE THEIR GREATEST USEFULNESS AS DIURETICS IN MGMNT OF EDEMA OF CHRONIC CARDIAC DECOMPENSATION. EDEMA DUE TO CHRONIC HEPATIC OR RENAL DISEASE ALSO RESPONDS FAVORABLY. WHEN EMPLOYED IN HYPERTENSIVE DISEASE, WITH OR WITHOUT OVERT EDEMA, THESE AGENTS HAVE HYPOTENSIVE ACTION... /BENZOTHIADIAZIDES/

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 832


4.2 Drug Warning

PLASMA POTASSIUM CONCN SHOULD BE DETERMINED PERIODICALLY IN PT WHO RECEIVE THIAZIDE DIURETICS FOR EXTENDED PERIODS. ...TO AVOID NEGATIVE POTASSIUM BALANCE, THIAZIDES ARE OFTEN PRESCRIBED IN COMBINATION WITH POTASSIUM CHLORIDE. /BENZOTHIADIAZIDES/

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 832


WHEN CARDIAC DECOMPENSATION OR HYPERTENSION IS ACCOMPANIED BY SIGNIFICANT IMPAIRMENT OF RENAL FUNCTION, THIAZIDES SHOULD BE ADMIN WITH CAUTION BECAUSE OF THEIR CAPACITY TO AGGRAVATE RENAL INSUFFICIENCY.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 832


5 Pharmacology and Biochemistry
5.1 Absorption, Distribution and Excretion

THIAZIDES ARE ABSORBED FROM GASTROINTESTINAL TRACT & OWE THEIR USEFULNESS LARGELY TO THEIR EFFECTIVENESS BY ORAL ROUTE. ABSORPTION IS RELATIVELY RAPID. ... DRUG PASSES READILY THROUGH PLACENTAL BARRIER TO FETUS. ... MOST COMPD ARE RAPIDLY EXCRETED WITHIN 3-6 HR. /BENZOTHIADIAZIDES/

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 831


5.2 Mechanism of Action

INHIBITION OF CARBONIC ANHYDRASE DECR CONCN OF HYDROGEN ION AVAILABLE FOR EXCHANGE. DECR HYDROGEN-ION CONCN LEADS TO NATRIURESIS & THEREFORE DIURESIS. USE OF CARBONIC ANHYDRASE INHIBITOR DOES NOT GREATLY ALTER CHLORIDE EXCRETION. HOWEVER, THERE MAY BE MARKED POTASSIUM LOSS WITH RESULTING HYPOKALEMIA. /DIURETICS/

Evaluations of Drug Interactions. 2nd ed. and supplements. Washington, DC: American Pharmaceutical Assn., 1976, 1978., p. 418


DOMINANT ACTION OF THIAZIDES IS TO INCR RENAL EXCRETION OF SODIUM & CHLORIDE & ACCOMPANYING VOL OF WATER. UNLIKE BOTH MERCURIALS & CARBONIC ANHYDRASE INHIBITORS, ACTION OF THIAZIDES IS VIRTUALLY INDEPENDENT OF ACID-BASE BALANCE. THIAZIDES ALSO EVOKE SIGNIFICANT AUGMENTATION OF POTASSIUM EXCRETION... /BENZOTHIADIAZIDES/

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 830


THIAZIDES ARE...SECRETED INTO TUBULAR FLUID BY ACTIVE PROCESS LOCATED IN PROXIMAL SEGMENT. ... THIAZIDES INHIBIT REABSORPTION OF SODIUM & ITS ATTENDANT ANION, CHLORIDE, IN DISTAL SEGMENT. ... AUGMENTED EXCRETION OF.../POTASSIUM/ RESULTS FROM ITS INCR SECRETION BY DISTAL TUBULE. /BENZOTHIADIAZIDES/

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 830